
CORD-19:f22ac602926d152936dd6af839da45bf8290e038 / 11264-11449
Annnotations
{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/f22ac602926d152936dd6af839da45bf8290e038","sourcedb":"CORD-19","sourceid":"f22ac602926d152936dd6af839da45bf8290e038","text":"In recent years, several classes of RAS inhibitors have been developed and these inhibitors are effective in hypertensive patients and in hypertension-associated pathological disorders.","tracks":[{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T90","span":{"begin":0,"end":185},"obj":"Sentence"}],"attributes":[{"subj":"T90","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T90","span":{"begin":0,"end":185},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T90","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19-PD-HP","denotations":[{"id":"T11","span":{"begin":138,"end":150},"obj":"Phenotype"}],"attributes":[{"id":"A11","pred":"hp_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/HP_0000822"},{"subj":"T11","pred":"source","obj":"CORD-19-PD-HP"}]},{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T45","span":{"begin":36,"end":39},"obj":"Body_part"}],"attributes":[{"id":"A45","pred":"uberon_id","subj":"T45","obj":"http://purl.obolibrary.org/obo/UBERON_0018229"},{"subj":"T45","pred":"source","obj":"CORD-19-PD-UBERON"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T77","span":{"begin":138,"end":150},"obj":"Disease"},{"id":"T69488","span":{"begin":138,"end":150},"obj":"Disease"}],"attributes":[{"id":"A77","pred":"mondo_id","subj":"T77","obj":"http://purl.obolibrary.org/obo/MONDO_0005044"},{"id":"A31012","pred":"mondo_id","subj":"T69488","obj":"http://purl.obolibrary.org/obo/MONDO_0005044"},{"subj":"T77","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T69488","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19_Custom_license_subset","color":"#93d5ec","default":true},{"id":"CORD-19-Sentences","color":"#ece893"},{"id":"CORD-19-PD-HP","color":"#ce93ec"},{"id":"CORD-19-PD-UBERON","color":"#93ecb4"},{"id":"CORD-19-PD-MONDO","color":"#ec9a93"}]}]}}